User menu

Accès à distance ? S'identifier sur le proxy UCLouvain | Saint-Louis

Search

Displaying 8 results.
    • Journal article
    ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): Final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
    Mounier, N. Brice, P. Bologna, S. Briere, J. Gaillard, I. Heczko, M. Gabarre, J. Casasnovas, O. Jaubert, J. Colin, P. Delmer, A. Devidas, A. Bachy, E. Nicolas-Virelizier, E. Aoudjhane, A. Humbrecht, C. André, M.[UCL] Carde, P. Divine, M. Fenaux, P. Coiffier, B. Reman, O. Aoudjhane, M. Blaise, A.M. Bordessoule, D. Bosly, André[UCL] Morschhauser, F. Caillot, D. Gonzalez, H. Lederlin, P. Bouabdallah, R. van Hoof, A. Boulat, O. Bauduer, F. Tournilhac, O. Decaudin, D. Sebban, C. Janvier, M. Kentos, A. Voillat, L. Fabbro, M. Eisenmann, J.C. Martin, C. Christian, B. Ferrant, Augustin[UCL] Salanoubat, C. Varet, B. Bouabdallah, K. de Prijck, B. Levaltier, X. Castaigne, S. Audhuy, B. Frenkiel, N. Rose, C. Fitoussi, O. Orfeuvre, H. Pignon, J.M. (2014) Annals of Oncology — Vol. 25, no.8, p. 1622-1628 (2014)
    • Journal article
    Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II lymphoma study Association trial
    Mounier, N. El Gnaoui, T. Tilly, H. Canioni, D. Sebban, C. Casasnovas, R.-O. Delarue, R. Sonet, Anne[UCL] Beaussart, P. Petrella, T. Castaigne, S. Bologna, S. Salles, G. Rahmouni, A. Gaulard, P. Haioun, C. (2013) Haematologica : journal of hematology — Vol. 98, no.11, p. 1726-1731 (2013)
    • Speech
    THE LONG-TERM OUTCOME OF ELDERLY PATIENTS WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL) IN THE IMATINIB ERA
    Delannoy, André[UCL] Delabesse, E. Lheritier, V. Castaigne, S. Rigal-Huguet, F. Raffoux, E. Garban, F. Legrand, O. Bologna, S. Dubruille, V. Turlure, Pascal Reman, O. Delain, M. Isnard, F. Coso, D. Raby, P. Buzyn, A. Cailleres, S. Darre, S. Fohrer, C. Sonet, Anne Bilhou-Nabera, C. Bene, M. -C. Dombret, H. Thomas, X. (2009) 14th Annual Meeting of the European-Hematology-Association — Berlin (Germany)
    • Journal article
    Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): A randomised phase 3 trial
    Delarue, R. Tilly, H. Mounier, N. Petrella, T. Salles, G. Thieblemont, C. Bologna, S. Ghesquières, H. Hacini, M. Fruchart, C. Ysebaert, L. Fermé, C. Casasnovas, O. Van Hoof, A. Thyss, A. Delmer, A. Fitoussi, O. Molina, T.J. Haioun, C. Bosly, André[UCL] (2013) The Lancet Oncology — Vol. 14, no.6, p. 525-533 (2013)
    • Journal article
    Parenthood in survivors of Hodgkin lymphoma: An EORTC-GELA general population case-control study
    Van Der Kaaij, M.A.E. Heutte, N. Meijnders, P. Abeilard-Lemoisson, E. Spina, M. Moser, L.C. Allgeier, A. Meulemans, B. Dubois, B. Simons, A.H.M. Lugtenburg, P.J. Aleman, B.M.P. Noordijk, E.M. Fermé, C. Thomas, J. Stamatoullas, A. Fruchart, C. Brice, P. Gaillard, I. Doorduijn, J.K. Sebban, C. Smit, W.G.J.M. Bologna, S. Roesink, J.M. Ong, F. André, Marc[UCL] Raemaekers, J.M.M. Henry-Amar, M. Kluin-Nelemans, H.C. (2012) Journal of Clinical Oncology — Vol. 30, no.31, p. 3854-3863 (2012)
    • Journal article
    Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of Hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: Results of the GRAAL1
    Coiffier, B. Mounier, N. Bologna, S. Ferme, C Tilly, H. Sonet, Anne Christian, B. Casasnovas, O. Jourdan, E Belhadj, K Herbrecht, R. (2003) Journal of Clinical Oncology — Vol. 21, no. 23, p. 4402-4406 (2003)
    • Journal article
    Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1b)
    Ketterer, N. Coiffier, B. Thieblemont, C. Fermé, C. Brière, J. Casasnovas, O. Bologna, S. Christian, B. Connerotte, Thierry[UCL] Réher, C. Bordessoule, D. Fruchart, C. Delarue, R. Bonnet, C. Morschhauser, F. Anglaret, B. Soussain, C. Fabiani, B. Tilly, H. Haioun, C. (2013) Annals of Oncology — Vol. 24, no. 4, p. 1032-1037 (2013)
    • Speech
    Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study).
    Coiffier, B. Mounier, N. Bologna, S. Ferme, C Herbrecht, R. Tilly, H. Sonet, Anne Christian, B. Casasnovas, O. Jourdan, E Belhadj, K (2002) 44th Annual Meeting of the American-Society-of-Hematology — PHILADELPHIA(Pennsylvania)